SSIs offer risks, not benefits during pregnancy, study says

11/2/2012 | Medscape (free registration)

Taking selective serotonin reuptake inhibitors while pregnant raises a woman's risk of miscarriage, preterm birth and neonatal complications, researchers from Beth Israel Deaconess Medical Center reported. They said there isn't strong data showing benefits, either for mothers or infants, and advised women to discuss use of the medications with their health care practitioner.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA